Orexin Agonist Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Orexin Agonist Program. Real-time updates on events, politics, business and more.

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

March 28, 2024

Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...

City Of United Kingdom United States Kristenk Sheppard Centessa Pharmaceuticals Technology Platform

Source: marketscreener.com

Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders -October 25, 2023 at 08:00 am EDT

October 25, 2023

- Preclinical data demonstrated significant activity at low doses of ORX750 in highly predictive translational models of Narcolepsy Type 1 - ORX750 advancing in IND-enabling studies; Clinical proof...

United States City Of United Kingdom Rio De Janeiro Estado Do Rio Orexin Ataxin

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Orexin Agonist Program News Today

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders -October 25, 2023 at 08:00 am EDT

Explore More Categories